Terug
Ook genoteerd als
SRHGF
OTC
Dagbereik
€ 15,82
€ 16,29
52-Weeksbereik
€ 12,69
€ 17,50
Volume
9
50D / 200D Gem.
€ 16,48
/
€ 16,13
Vorige Slotkoers
€ 16,12
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,2 | 11,1 |
| P/B | 0,3 | 1,4 |
| ROE % | 26,2 | 10,7 |
| Net Margin % | 3,0 | 5,2 |
| Rev Growth 5Y % | 10,7 | 8,1 |
| D/E | 1,9 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
295,33B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
272,43B | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | N/A | € 0,39 | — |
| 2025-09-01 | N/A | € 0,40 | — |
| 2025-03-03 | N/A | € 0,37 | — |
| 2024-09-03 | N/A | € 0,29 | — |
| 2024-03-05 | N/A | € 0,34 | — |
| 2023-06-30 | N/A | € 0,27 | — |
| 2023-01-01 | N/A | € 0,31 | — |
| 2022-06-30 | N/A | € 0,34 | — |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,44%
Growth (3Y)
-0,07%
Growth (5Y)
8,61%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 27, 2026 | Apr 09, 2026 | € 0,13 | 2,17% |
| Sep 26, 2025 | Oct 09, 2025 | € 0,21 | 2,28% |
| Mar 28, 2025 | Apr 10, 2025 | € 0,16 | 2,32% |
| Sep 27, 2024 | Oct 10, 2024 | € 0,19 | 1,83% |
| Mar 27, 2024 | Apr 12, 2024 | € 0,14 | 2,80% |
| Sep 28, 2023 | Oct 12, 2023 | € 0,22 | 2,84% |
| Apr 05, 2023 | Apr 21, 2023 | € 0,13 | 2,88% |
| Sep 29, 2022 | Oct 13, 2022 | € 0,21 | 3,09% |
| Apr 07, 2022 | Apr 21, 2022 | € 0,16 | 2,60% |
| Sep 30, 2021 | Oct 14, 2021 | € 0,25 | 3,33% |
| Apr 08, 2021 | Apr 22, 2021 | € 0,13 | 2,77% |
| Oct 01, 2020 | Oct 15, 2020 | € 0,14 | 3,25% |
| Mar 12, 2020 | Mar 26, 2020 | € 0,10 | 3,84% |
| Sep 05, 2019 | Sep 19, 2019 | € 0,11 | 3,23% |
| Mar 14, 2019 | Mar 28, 2019 | € 0,11 | 3,02% |
| Sep 06, 2018 | Sep 20, 2018 | € 0,20 | 3,24% |
| Mar 15, 2018 | Mar 29, 2018 | € 0,17 | 2,23% |
| Sep 07, 2017 | Sep 21, 2017 | € 0,25 | 2,61% |
| Mar 15, 2017 | Mar 30, 2017 | € 0,14 | 2,45% |
| Sep 07, 2016 | — | € 0,21 | 2,67% |
Belangrijkste Punten
Revenue grew 10,74% annually over 5 years — strong growth
Earnings grew 21,40% over the past year
ROE of 26,16% indicates high profitability
Generating 2,99B in free cash flow
P/E of 1,15 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,76%
Groei
Revenue Growth (5Y)
10,74%
Revenue (1Y)4,98%
Earnings (1Y)21,40%
FCF Growth (3Y)-2,22%
Kwaliteit
Return on Equity
26,16%
ROIC13,02%
Net Margin3,00%
Op. Margin5,91%
Veiligheid
Debt / Equity
1,85
Current Ratio1,19
Interest Coverage2,92
Waardering
P/E Ratio
1,15
Forward P/EN/A
P/B Ratio0,29
EV/EBITDA3,66
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,98% | Revenue Growth (3Y) | 8,42% |
| Earnings Growth (1Y) | 21,40% | Earnings Growth (3Y) | 13,52% |
| Revenue Growth (5Y) | 10,74% | Earnings Growth (5Y) | 11,88% |
| Profitability | |||
| Revenue (TTM) | 252,70B | Net Income (TTM) | 7,59B |
| ROE | 26,16% | ROA | 6,07% |
| Gross Margin | 24,31% | Operating Margin | 5,91% |
| Net Margin | 3,00% | Free Cash Flow (TTM) | 2,99B |
| ROIC | 13,02% | FCF Growth (3Y) | -2,22% |
| Safety | |||
| Debt / Equity | 1,85 | Current Ratio | 1,19 |
| Interest Coverage | 2,92 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,44% |
| Dividend Growth (3Y) | -0,07% | Dividend Growth (5Y) | 8,61% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 1,15 | Forward P/E | N/A |
| P/B Ratio | 0,29 | P/S Ratio | 0,03 |
| PEG Ratio | 1,61 | Forward PEG | N/A |
| EV/EBITDA | 3,66 | Fwd EV/EBITDA | 2,01 |
| Forward P/S | 0,03 | Fwd Earnings Yield | N/A |
| FCF Yield | 34,14% | ||
| Market Cap | 8,74B | Enterprise Value | 54,67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 252,70B | 240,72B | 214,96B | 184,08B | 168,03B |
| Net Income | 7,59B | 6,25B | 5,89B | 5,71B | 4,84B |
| EPS (Diluted) | 13,93 | 11,44 | 10,78 | 10,44 | 8,74 |
| Gross Profit | 61,44B | 54,82B | 51,71B | 45,06B | 41,21B |
| Operating Income | 14,94B | 13,16B | 12,34B | 10,81B | 9,66B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 124,94B | 112,33B | 102,36B | 91,46B | 77,07B |
| Total Liabilities | 94,83B | 84,60B | 76,08B | 65,83B | 55,86B |
| Shareholders' Equity | 30,19B | 27,79B | 26,13B | 25,48B | 21,08B |
| Total Debt | 55,88B | 49,37B | 48,55B | 42,13B | 34,22B |
| Cash & Equivalents | 9,95B | 11,73B | 12,55B | 10,67B | 7,95B |
| Current Assets | 52,87B | 50,06B | 47,87B | 39,67B | 32,06B |
| Current Liabilities | 44,54B | 41,54B | 37,42B | 32,49B | 28,29B |
Strategiescores
This stock passed the criteria for 0 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026